APDNX
Price
$16.83
Change
-$0.00 (-0.00%)
Updated
Jun 4 closing price
Net Assets
57.88M
VIVIX
Price
$66.84
Change
-$0.13 (-0.19%)
Updated
Jun 5 closing price
Net Assets
188.77B
Interact to see
Advertisement

APDNX vs VIVIX

Header iconAPDNX vs VIVIX Comparison
Open Charts APDNX vs VIVIXBanner chart's image
Artisan Select Equity Advisor
Price$16.83
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets57.88M
Vanguard Value Index I
Price$66.84
Change-$0.13 (-0.19%)
VolumeN/A
Net Assets188.77B
APDNX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
APDNX vs. VIVIX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APDNX is a Hold and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 189B vs. APDNX (57.9M). VIVIX pays higher dividends than APDNX: VIVIX (2.29) vs APDNX (0.18). APDNX was incepted earlier than VIVIX: APDNX (5 years) vs VIVIX (27 years). APDNX (3.84) is less costly to investors than VIVIX (0.04). APDNX is a more actively managed with annual turnover of: 19.09 vs. VIVIX (9.00). APDNX has a lower initial minimum investment than VIVIX: APDNX (250000) vs VIVIX (5000000). APDNX annual gain was more profitable for investors over the last year : 14.23 vs. VIVIX (6.89). APDNX return over 5 years is better than : 70.09 vs. VIVIX (58.98).
APDNXVIVIXAPDNX / VIVIX
Total Expense Ratio1.160.042,900%
Annual Report Gross Expense Ratio3.840.049,600%
Fund Existence5 years27 years-
Gain YTD9.4281.452649%
Front LoadN/AN/A-
Min. Initial Investment25000050000005%
Min. Initial Investment IRAN/AN/A-
Net Assets57.9M189B0%
Annual Yield % from dividends0.182.298%
Returns for 1 year14.236.89207%
Returns for 3 years42.3120.06211%
Returns for 5 years70.0958.98119%
Returns for 10 yearsN/A103.63-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYOIX63.08N/A
N/A
Rydex Biotechnology Inv
JSCRX18.47N/A
N/A
PGIM Jennison Small Company R
TVRVX23.78N/A
N/A
Third Avenue Real Estate Value Investor
HFDYX18.90N/A
N/A
Hartford Schroders US MidCap Opps Y
JUEQX24.90N/A
N/A
JPMorgan US Equity R4